PaloBiofarma
About:
Innovation Through Medicinal Chemistry
Website: http://www.palobiofarma.com
Top Investors: European Innovation Council, Inveready, SODENA, The Foundation for Prader-Willi Research, Fitalent
Description:
Palobiofarma is a Spanish Biotech company located in Barcelona’s Science Park. Our mission is to discover and develop new drugs based on the modulation of the adenosine receptors. Our vision is to be the first european adenosine drug discovery company
Total Funding Amount:
16M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Barcelona, Catalonia, Spain
Founded Date:
2005-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-02-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai